|
1
|
Chung WS, Lin CL, Ho FM, Li RY, Sung FC,
Kao CH and Yeh JJ: Asthma increases pulmonary thromboembolism risk:
A nationwide population cohort study. Eur Respir J. 43:801–817.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shokoufeh H, Kerman SR, Mojtaba K, Vaferi
H, Ramezani R, Jourshari NM, Mousavi SA and Pouraliakbar H:
Accuracy of D-dimer: Fibrinogen ratio to diagnose pulmonary
thromboembolism in patients admitted to intensive care units.
Cardiovasc J Afr. 23:446–456. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shah N, Shah D, Shah S, Gohil Y, Vasani B
and Patel A: Computed tomography angiography in chronic pulmonary
thromboembolism. Apollo Med. 8:44–52. 2011. View Article : Google Scholar
|
|
4
|
Perrier A, Roy PM, Aujesky D, Chagnon I,
Howarth N, Gourdier AL, Leftheriotis G, Barghouth G, Cornuz J,
Hayoz D and Bounameaux H: Diagnosing pulmonary embolism in
outpatients with clinical assessment, D-dimer measurement, venous
ultrasound, and helical computed tomography: A multicenter
management study. Am J Med. 116:291–299. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Righini M, Le Gal G, Aujesky D, Roy PM,
Sanchez O, Verschuren F, Rutschmann O, Nonent M, Cornuz J, Thys F,
et al: Diagnosis of pulmonary embolism by multidetector CT alone or
combined with venous ultrasonography of the leg: A randomised
non-inferiority trial. Lancet. 371:1343–1352. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schluger N, Henschke C, King T, Russo R,
Binkert B, Rackson M and Hayt D: Diagnosis of pulmonary embolism at
a large teaching hospital. J Thorac Imaging. 9:180–184. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Konstantinides SV, Torbicki A, Agnelli G,
Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M,
Kucher N, et al: 2014 ESC guidelines on the diagnosis and
management of acute pulmonary embolism. Eur Heart J. 35:3033–3069,
3069a-3069k. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adam SS, Key NS and Greenberg CS: D-dimer
antigen: Current concepts and future prospects. Blood.
113:2878–2887. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirsh J and Lee AY: How we diagnose and
treat deep vein thrombosis. Blood. 99:3102–3110. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lippi G, Cervellin G, Franchini M and
Favaloro EJ: Biochemical markers for the diagnosis of venous
thromboembolism: The past, present and future. J Thromb
Thrombolysis. 30:459–471. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rafee A, Herlikar D, Gilbert R, Stockwell
RC and Mclauchlan GJ: D-Dimer in the diagnosis of deep vein
thrombosis following total hip and knee replacement: A prospective
study. Ann R Coll Surg Engl. 90:123–126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arraud N, Linares R, Tan S, Gounou C,
Pasquet JM, Mornet S and Brisson AR: Extracellular vesicles from
blood plasma: Determination of their morphology, size, phenotype
and concentration. J Thromb Haemost. 12:614–627. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu ZH, Ji CL, Li H, Qiu GX, Gao CJ and
Weng XS: Membrane microparticles and diseases. Eur Rev Med
Pharmacol Sci. 17:2420–2427. 2013.PubMed/NCBI
|
|
14
|
Liu ML, Reilly MP, Casasanto P, Mckenzie
SE and Williams KJ: Cholesterol enrichment of human
monocyte/macrophages induces surface exposure of phosphatidylserine
and the release of biologically-active tissue factor-positive
microvesicles. Arterioscler Thromb Vasc Biol. 27:430–435. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takahashi T, Kato A, Berdnikovs S, Stevens
WW, Suh LA, Norton JE, Carter RG, Harris KE, Peters AT, Hulse KE,
et al: Microparticles in nasal lavage fluids in chronic
rhinosinusitis: Potential biomarkers for diagnosis of
aspirin-exacerbated respiratory disease. J Allergy Clin Immunol.
140:720–729. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu YJJ, Hua CC, Chen JY, Chang YW and
Tseng JC: The role of endothelial microparticles in autoimmune
disease patients with Raynaud's phenomenon. J Microbiol Immunol
Infect. 50:857–862. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Christersson C, Thulin à and Siegbahn A:
Microparticles during long-term follow-up after acute myocardial
infarction. Association to atherosclerotic burden and risk of
cardiovascular events. Thromb Haemost. 117:1571–1581. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Awad HA, Tantawy AA, Elfarrash RA, Ismail
EA and Youssif NM: CD144+ endothelial microparticles as a marker of
endothelial injury in neonatal ABO blood group incompatibility.
Blood Transfus. 12:250–259. 2014.PubMed/NCBI
|
|
19
|
Takahashi T, Kobayashi S, Fujino N, Suzuki
T, Ota C, Tando Y, Yamada M, Yanai M, Yamaya M, Kurosawa S, et al:
Annual FEV1 changes and numbers of circulating endothelial
microparticles in patients with COPD: A prospective study. BMJ
Open. 4:e0045712014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
György B, Szabó TG, Pásztói M, Pál Z,
Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, et al:
Membrane vesicles, current state-of-the-art: Emerging role of
extracellular vesicles. Cell Mol Life Sci. 68:2667–2688. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Zhang S, Luo L, Norström E, Braun
OÖ, Mörgelin M and Thorlacius H: Platelet-derived microparticles
regulates thrombin generation via phophatidylserine in abdominal
sepsis. J Cell Physiol. 233:1051–1060. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Horn P, Erkilet G, Veulemans V, Kröpil P,
Schurgers L, Zeus T, Heiss C, Kelm M and Westenfeld R:
Microparticle-induced coagulation relates to coronary artery
atherosclerosis in severe aortic valve stenosis. PLoS One.
11:e01514992016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bidot L, Jy W, Bidot C Jr, Jimenez JJ,
Fontana V, Horstman LL and Ahn YS: Microparticle-mediated thrombin
generation assay: Increased activity in patients with recurrent
thrombosis. J Thromb Haemost. 6:913–919. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao L, Bi Y, Kou J, Shi J and Piao D:
Phosphatidylserine exposing-platelets and microparticles promote
procoagulant activity in colon cancer patients. J Exp Clin Cancer
Res. 35:542016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nijiati M, Saidaming A and Guoqing L: In
vitro study of the thrombogenic activity of platelet-derived
microparticles from patients with acute coronary syndrome. Ann Clin
Lab Sci. 47:156–161. 2017.PubMed/NCBI
|
|
26
|
Bal L, Ederhy S, Di Angelantonio E, Toti
F, Zobairi F, Dufaitre G, Meuleman C, Mallat Z, Boccara F, Tedgui
A, et al: Factors influencing the level of circulating procoagulant
microparticles in acute pulmonary embolism. Arch Cardiovasc Dis.
103:394–403. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu L and Fu YY: The role of platelet
microparticles in pulmonary thromboembolism. Clinical Research and
Practice. 11:187–189. 2017.(In Chinese).
|
|
28
|
Christersson C, Lindahl B and Siegbahn A:
The composition and daily variation of microparticles in whole
blood in stable coronary artery disease. Scand J Clin Lab Invest.
76:25–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bucciarelli P, Martinelli I, Artoni A,
Passamonti SM, Previtali E, Merati G, Tripodi A and Mannucci PM:
Circulating microparticles and risk of venous thromboembolism.
Thromb Res. 129:591–197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ramacciotti E, Hawley AE, Farris DM,
Ballard NE, Wrobleski SK, Myers DD Jr, Henke PK and Wakefield TW:
Leukocyte- and platelet-derived microparticles correlate with
thrombus weight and tissue factor activity in an experimental mouse
model of venous thrombosis. Thromb Haemost. 101:748–754.
2009.PubMed/NCBI
|
|
31
|
Freyssinet JM: Cellular microparticles:
what are they bad or good for? J Thromb Haemost. 1:1655–1662. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Biró E, Sturk-Maquelin KN, Vogel GMT,
Meuleman DG, Smit MJ, Hack CE, Sturk A and Nieuwland R: Human
cell-derived microparticles promote thrombus formation in vivo in a
tissue factor-dependent manner. J Thromb Haemost. 1:2561–2568.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qi H, Zhong Z, Zhou HX, Deng CY, Zhu H, Li
JF, Wang XL and Li FR: A rapid and highly sensitive protocol for
the detection of Escherichia coli O157:H7 based on
immunochromatography assay combined with the enrichment technique
of immunomagnetic nanoparticles. Int J Nanomedicine. 6:3033–3039.
2011.PubMed/NCBI
|
|
34
|
Rectenwald JE, Myers DD Jr, Hawley AE,
Longo C, Henke PK, Guire KE, Schmaier AH and Wakefield TW: D-dimer,
P-selectin, and microparticles: novel markers to predict deep
venous thrombosis. A pilot study. Thromb Haemost. 94:1312–1317.
2005.PubMed/NCBI
|
|
35
|
Floresnascimento MC, Beltrame MP, De Paula
EV, Montalvão SL, Pereira FG, Orsi FL, Lorand-Metze I and
Annichino-Bizzacchi JM: Microparticles in deep venous thrombosis,
antiphospholipid syndrome and Factor V Leiden. Platelets.
20:367–375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee JA and Zierler BK: The current state
of practice in the diagnosis of venous thromboembolism at an
academic medical center. Vasc Endovascular Surg. 45:22–27. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang J, Chen Y, Cai Z and Chen P:
Diagnostic value of platelet indices for pulmonary embolism: The
authors respond. Am J Emerg Med. 33:10942015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tang N, Sun Z, Li D, Yang J, Yin S and
Guan Q: Combined measurement of factor XIII and D-dimer is helpful
for differential diagnosis in patients with suspected pulmonary
embolism. Clin Chem Lab Med. 55:1948–1953. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Napoleão P, Monteiro Mdo C, Cabral LB,
Criado MB, Ramos C, Selas M, Viegas-Crespo AM, Saldanha C, Carmo
MM, Ferreira RC and Pinheiro T: Changes of soluble CD40 ligand in
the progression of acute myocardial infarction associate to
endothelial nitric oxide synthase polymorphisms and vascular
endothelial growth factor but not to platelet CD62P expression.
Transl Res. 166:650–659. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
George R, Bhatt A, Narayani J,
Thulaseedharan JV, Sivadasanpillai H and Tharakan JA: Enhanced
P-selectin expression on platelet-a marker of platelet activation,
in young patients with angiographically proven coronary artery
disease. Mol Cell Biochem. 419:125–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Prakash P, Nayak MK and Chauhan AK:
P-selectin can promote thrombus propagation independently of both
von Willebrand factor and thrombospondin-1 in mice. J Thromb
Haemost. 15:388–394. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Graf ME, Sookthai D, Johnson T, Schübel R,
Katzke V, Bugert P, Hoffmeister M, Kaaks R and Kühn T: Biological
reproducibility of circulating P-Selectin, Thrombopoietin,
GPIIb/IIIa and Thrombomodulin over one year. Clin Biochem.
50:942–946. 2017. View Article : Google Scholar : PubMed/NCBI
|
